申请人:KASINA LAILA INNOVA PHARMACEUTICALS PRIVATE LIMITED
公开号:US20140086837A1
公开(公告)日:2014-03-27
The invention relates to
18
F-labeled compounds of formula (I), hydrates, isomers, or pharmaceutically acceptable salts thereof, process for their preparation and pharmaceutical compositions. The invention relates to the methods of diagnosing kidney function in humans by PET imaging.
这项发明涉及到式(I)的18F标记化合物,以及它们的水合物、异构体或药学上可接受的盐,以及它们的制备方法和药物组合物。该发明涉及通过PET成像诊断人类肾功能的方法。